Published in Diabetes Care on February 01, 1999
Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta (2009) 2.05
Retracted Alpha-lipoic acid supplementation and diabetes. Nutr Rev (2008) 1.86
Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm (2010) 1.49
Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev (2014) 1.16
Oxidative stress in diabetes: implications for vascular and other complications. Int J Mol Sci (2013) 1.13
Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid. Am J Physiol Regul Integr Comp Physiol (2010) 0.97
Modulation of oxidative stress-induced changes in hypertension and atherosclerosis by antioxidants. Exp Clin Cardiol (2006) 0.94
Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys (2009) 0.93
Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J (2010) 0.89
Early pregnancy urinary biomarkers of fatty acid and carbohydrate metabolism in pregnancies complicated by gestational diabetes. Diabetes Res Clin Pract (2014) 0.80
Effect of moderately high dietary salt and lipoic acid on blood pressure in Wistar-Kyoto rats. Exp Clin Cardiol (2007) 0.80
Lipoic acid attenuates innate immune infiltration and activation in the visceral adipose tissue of obese insulin resistant mice. Lipids (2011) 0.78
Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function. Sci Rep (2016) 0.78
Dietary supplements in the management of hypertension and diabetes - a review. Afr J Tradit Complement Altern Med (2014) 0.77
α-Lipoic acid ameliorates impaired glucose uptake in LYRM1 overexpressing 3T3-L1 adipocytes through the IRS-1/Akt signaling pathway. J Bioenerg Biomembr (2012) 0.77
Advances in diabetes for the millennium: nutritional therapy of type 2 diabetes. MedGenMed (2004) 0.75
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82
alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med (1995) 3.58
Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med (1992) 3.41
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism (1998) 2.65
mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet (1991) 2.53
The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev (2001) 2.53
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther (2007) 2.38
Global identifiability of nonlinear models of biological systems. IEEE Trans Biomed Eng (2001) 2.33
Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg (1998) 2.16
Generalized sensitivity functions in physiological system identification. Ann Biomed Eng (1999) 2.15
[Successful multiple resuscitation in flecainide poisoning]. Dtsch Med Wochenschr (1992) 2.04
Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med (1997) 1.99
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab (1997) 1.78
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol (1980) 1.69
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Microcirculatory changes in sodium taurocholate-induced pancreatitis in rats. Am J Physiol (1991) 1.65
Modular closed-loop control of diabetes. IEEE Trans Biomed Eng (2012) 1.61
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56
Oestrogen treatment of constitutional tall stature: a risk-benefit ratio. Arch Dis Child (1998) 1.53
Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics (2005) 1.52
Is the minimal model too minimal? Diabetologia (1996) 1.52
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52
Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med (1999) 1.51
Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest (1985) 1.49
The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes (1997) 1.48
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther (2009) 1.48
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
Global identifiability of linear compartmental models--a computer algebra algorithm. IEEE Trans Biomed Eng (1998) 1.46
Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med (1991) 1.45
Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med (1998) 1.43
A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies Type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia (2002) 1.41
Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics (1991) 1.41
The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag (2001) 1.40
HLA-DR2 and sleep onset REM periods in endogenous depression. Br J Psychiatry (1988) 1.38
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med (1998) 1.36
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy. Clin Pharmacol Ther (2009) 1.33
Models of subcutaneous insulin kinetics. A critical review. Comput Methods Programs Biomed (2000) 1.32
A compartmental model of zinc metabolism in healthy women using oral and intravenous stable isotope tracers. Am J Clin Nutr (1997) 1.31
Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab (1997) 1.31
Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes. Diabetes Obes Metab (2007) 1.30
Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors (1997) 1.29
Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology (1992) 1.29
Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol (1987) 1.28
A minimal input-output configuration for a priori identifiability of a compartmental model of leucine metabolism. IEEE Trans Biomed Eng (1993) 1.28
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest (1996) 1.28
Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab (2000) 1.25
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach. Diabetes Obes Metab (2008) 1.24
Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab (2001) 1.22
Characterization of a rat pancreatic secretory protein associated with pancreatitis. Gastroenterology (1991) 1.22
Cytoprotection - organoprotection by somatostatin: gastric and hepatic lesions. Experientia (1982) 1.21
Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes (1995) 1.21
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res (1999) 1.19
The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol (1997) 1.19
Minimal modeling, partition analysis, and the estimation of insulin sensitivity. Fed Proc (1980) 1.18
A markerless motion capture system to study musculoskeletal biomechanics: visual hull and simulated annealing approach. Ann Biomed Eng (2006) 1.16
Muscle blood flow and flow heterogeneity during exercise studied with positron emission tomography in humans. Eur J Appl Physiol (2000) 1.16
Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technol Ther (2010) 1.16
Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med (1998) 1.16
Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab (1999) 1.15
Validation of mathematical models of complex endocrine-metabolic systems. A case study on a model of glucose regulation. Med Biol Eng Comput (1983) 1.14
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes (2000) 1.14
2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action. J Med Chem (2008) 1.14
Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters. Am J Physiol Endocrinol Metab (2009) 1.13
Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes (1993) 1.12
The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes (1996) 1.12
Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol (1986) 1.09
Elevated endothelin-1 levels after cigarette smoking. Metabolism (1994) 1.09
Estimation of protein fractional synthetic rate from tracer data. Am J Physiol (1993) 1.09
Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation (1998) 1.08
Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab (1995) 1.08
Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol (1999) 1.08
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther (1998) 1.07
Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res (2000) 1.07
Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia (2000) 1.06
Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B). Brain Dev (2001) 1.06
Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res (2001) 1.05
Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism (1995) 1.05
Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab (2001) 1.05
Early signs and course of disease of glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis (1995) 1.05
The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev (1987) 1.04
Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia (1998) 1.04
Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes (1997) 1.04
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha. Eur J Clin Invest (2000) 1.03
Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol (1990) 1.03
Effect of insulin on system A amino acid transport in human skeletal muscle. J Clin Invest (1993) 1.03
Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res (1993) 1.03